All In Biotech

Free tool

FAERS Monitor: Trisenox

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021248 or its brand name (Trisenox, Arsenic Trioxide). Reports on generic versions are filed under their own applications.

Reports

2,284

Serious

2,190

96% of reports

Hospitalization

957

Death reported

303

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • electrocardiogram qt prolonged264
  • differentiation syndrome227
  • off label use176
  • pyrexia107
  • pneumonia82
  • febrile neutropenia80
  • alanine aminotransferase increased79
  • dyspnoea75
  • neutropenia74
  • pleural effusion74
  • white blood cell count decreased73
  • drug ineffective71
  • nausea70
  • acute promyelocytic leukaemia differentiation syndrome67
  • anaemia66

Reports by year received

View as table
YearReports
2004141
2005110
200671
200764
200883
2009153
201038
201198
201285
201345
201480
201550
201656
201767
2018180
2019103
2020113
202188
2022149
2023125
2024147
2025149
202689

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,875 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute promyelocytic leukaemia differentiation syndromeSignal674379.83284.0195,875
differentiation syndromeSignal2274126.83548.2643,931
electrocardiogram qt prolongedSignal26468.160.817,287
alanine aminotransferase increasedSignal7911.99.6776
pleural effusionSignal7411.29.0679
febrile neutropeniaSignal8011.19.0728
white blood cell count decreasedSignal736.25.0315
neutropeniaSignal745.04.0235
anaemiaSignal663.22.598
pyrexiaSignal1072.82.4129
pneumoniaSignal822.31.962
off label use1761.91.671
dyspnoea751.21.03
nausea700.80.63
drug ineffective710.50.438

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.